Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Operating Margin: 2011-2025

Historic Operating Margin for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 11.79%.

  • Aytu Biopharma's Operating Margin fell 522.00% to 10.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.19%, marking a year-over-year decrease of 968.00%. This contributed to the annual value of 11.79% for FY2025, which is 845.00% down from last year.
  • As of FY2025, Aytu Biopharma's Operating Margin stood at 11.79%, which was down 252.71% from 3.34% recorded in FY2024.
  • Aytu Biopharma's Operating Margin's 5-year high stood at 3.34% during FY2024, with a 5-year trough of 113.69% in FY2022.
  • Over the past 3 years, Aytu Biopharma's median Operating Margin value was 11.79% (recorded in 2025), while the average stood at 10.34%.
  • Per our database at Business Quant, Aytu Biopharma's Operating Margin crashed by 2,400bps in 2022 and then soared by 9,780bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Operating Margin (MRY) stood at 89.70% in 2021, then decreased by 27bps to 113.69% in 2022, then soared by 86bps to 15.89% in 2023, then skyrocketed by 79bps to 3.34% in 2024, then plummeted by 253bps to 11.79% in 2025.
  • Its Operating Margin stands at 11.79% for FY2025, versus 3.34% for FY2024 and 15.89% for FY2023.